TVNewser TVSpy LostRemote SocialTimes AllFacebook FishbowlNY FishbowlDC PRNewser 10,000 Words GalleyCat UnBeige MediaJobsDaily

Posts Tagged ‘Ashish Verma’

Digitas Alum Verma Lands at Kelton

This slipped through the cracks last week, but we figured it’s worth mentioning that Ashish Verma, who previously led creative on all things Pfizer at Digitas Health, has joined up with research/strategy/design consultancy Kelton Global as managing director of its New York office. If you recall, Verma left Digitas Health last December after spending six years at the agency and most recently serving as SVP/creative director.

Now at Kelton, Verma will oversee innovation strategy and design consulting for Kelton’s East Coast clients (you can check out a list of case studies here if interested). Regarding the new hire, Kelton CEO Tom Bernthal says in a statement, “Ashish has that rare mix of creativity, marketing savvy, and leadership that makes this a perfect match. With our consumer insights platform, we believe we’re now uniquely positioned to develop strategies for clients that keep their customers at the center of their innovation and design efforts.”

Mediabistro Course

Online Production for Writers and Editors

Online Production for Writers and EditorsStarting October 30, learn how translate your written work into multi-dimensional and editorially relevant digital content! In this course you'll learn how to navigate a CMS, crop, resize, and optimize photos, create graphics, enhance static text through HTML/CSS, and measure the effectiveness of your content using analytics. Register now!

Verma Splitting from Digitas Health

We’re received confirmation that Digitas Health SVP, creative director Ashish Verma is leaving the agency. During his six-year run at Digitas Health, which recently realigned with the Publicis Healthcare Communications Group, Verma led creative on all the Pfizer business. The man himself could not reveal where he’s going to next due to confidentiality agreements and Digitas Health has yet to provide comment on the matter.